Spatial transcriptomics reveals early and progressive molecular changes in late-onset Pompe disease muscle

Abstract Late-onset Pompe disease (LOPD) is caused by acid alpha-glucosidase deficiency, leading to lysosomal glycogen accumulation and progressive muscle pathology. Muscle biopsies show marked fibre heterogeneity, including non-vacuolated and vacuolated fibres. This study aimed to define transcriptomic alterations across these fibre states using spatial transcriptomics. Spatial transcriptomics was performed on muscle sections using the GeoMx Digital Spatial Profiler with laminin and LC3B staining. A total of 76 areas of interest were analysed, including 9 control, 35 non-vacuolated Pompe (Pompe-NV), and 32 vacuolated Pompe (Pompe-V) regions. Genes expressed in at least 5% of regions in at least one condition were retained for downstream analysis. Differential expression, pathway enrichment, and patient-level analyses were performed. Pompe-NV regions already showed marked transcriptional alterations compared with controls, with enrichment of pathways related to mitochondrial function, redox homeostasis, stress-associated pro-apoptotic signalling, MAPK signalling, and structural remodelling. Pompe-V regions displayed a more advanced transcriptional state, with stronger cytokine-responsive, tissue injury/remodelling, and neuromuscular-associated programmes. Pathway-level analyses indicated that mitochondrial dysfunction, oxidative stress responses, pro-apoptotic stress signalling, and p38-associated stress-response signalling are early features of Pompe muscle. With increasing pathological severity, extracellular matrix, fibronectin matrix, vasculature-related, muscle structural remodelling, cytokine production, and tissue injury inflammatory remodelling programmes became more prominent. Regeneration-associated changes were detected across Pompe muscle but were most evident in vacuolated fibres, which showed increased central nucleation and NCAM1/LC3B co-localisation. Patient-level PCA further identified a severity-associated transcriptomic continuum. LOPD muscle follows a progressive molecular remodelling trajectory across disease states. Early disease is marked by stress-associated transcriptional remodelling, whereas more advanced pathology is associated with increasingly prominent extracellular, inflammatory, regenerative, and structural remodelling programmes.

Authors

Institutions

Publication Details

Journal
Acta Neuropathologica Communications
Published
2026-09-16
DOI
https://doi.org/10.1186/s40478-026-02424-6
Primary Topic
Lysosomal Storage Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Spatial transcriptomics reveals early and progressive molecular changes in late-onset Pompe disease muscle

Carmen Paradas, Eloy Rivas, James B Lilleker, Alexandra Monceau et al.
Acta Neuropathologica Communications
Lysosomal Storage Disorders Research
article

Spatial transcriptomics reveals early and progressive molecular changes in late-onset Pompe disease muscle

Carmen Paradas, Eloy Rivas, James B Lilleker, Alexandra Monceau, Margarita Chrysanthou-Piterou, Esther Fernández‐Simón, Olimpia Musumeci, Biruta Kierdaszuk, Eduard Gallardo, Mark Roberts, James Clark, George Papadimas, Jordi Díaz-Manera, Aurelio Hernández-Lain, Antonio Toscano, Anna Kostera-Pruszczyk, Constantinos Papadopoulos, Cristina Domínguez-González
article en

Abstract

Abstract Late-onset Pompe disease (LOPD) is caused by acid alpha-glucosidase deficiency, leading to lysosomal glycogen accumulation and progressive muscle pathology. Muscle biopsies show marked fibre heterogeneity, including non-vacuolated and vacuolated fibres. This study aimed to define transcriptomic alterations across these fibre states using spatial transcriptomics. Spatial transcriptomics was performed on muscle sections using the GeoMx Digital Spatial Profiler with laminin and LC3B staining. A total of 76 areas of interest were analysed, including 9 control, 35 non-vacuolated Pompe (Pompe-NV), and 32 vacuolated Pompe (Pompe-V) regions. Genes expressed in at least 5% of regions in at least one condition were retained for downstream analysis. Differential expression, pathway enrichment, and patient-level analyses were performed. Pompe-NV regions already showed marked transcriptional alterations compared with controls, with enrichment of pathways related to mitochondrial function, redox homeostasis, stress-associated pro-apoptotic signalling, MAPK signalling, and structural remodelling. Pompe-V regions displayed a more advanced transcriptional state, with stronger cytokine-responsive, tissue injury/remodelling, and neuromuscular-associated programmes. Pathway-level analyses indicated that mitochondrial dysfunction, oxidative stress responses, pro-apoptotic stress signalling, and p38-associated stress-response signalling are early features of Pompe muscle. With increasing pathological severity, extracellular matrix, fibronectin matrix, vasculature-related, muscle structural remodelling, cytokine production, and tissue injury inflammatory remodelling programmes became more prominent. Regeneration-associated changes were detected across Pompe muscle but were most evident in vacuolated fibres, which showed increased central nucleation and NCAM1/LC3B co-localisation. Patient-level PCA further identified a severity-associated transcriptomic continuum. LOPD muscle follows a progressive molecular remodelling trajectory across disease states. Early disease is marked by stress-associated transcriptional remodelling, whereas more advanced pathology is associated with increasingly prominent extracellular, inflammatory, regenerative, and structural remodelling programmes.

Acta Neuropathologica Communications
University of Messina (IT), National and Kapodistrian University of Athens (GR), Medical University of Warsaw (PL), Manchester Academic Health Science Centre (GB), Instituto de Salud Carlos III (ES), Hospital de Sant Pau (ES), Centre for Life (GB), Research Institute Hospital 12 de Octubre (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Hospital Universitario 12 De Octubre (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Salford Royal Hospital (GB), Muscular Dystrophy UK (GB), Eginition Hospital (GR), Hospital Universitario Virgen del Rocío (ES)
Good health and well-being
Openalex Percentile: Top 11%
Lysosomal Storage Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.